iClone AI Assistant: The Fully-Owned, AI-Powered Brand Representative for Your Business
SAN JOSE, Calif., Aug. 25, 2025 /PRNewswire/ — Reallusion, a pioneer in 3D character animation
SAN JOSE, Calif., Aug. 25, 2025 /PRNewswire/ — Reallusion, a pioneer in 3D character animation
Self-employed barbers and booth renters face mounting IRS challenges as unreported cash income and unpaid
RMTG Subsidiary Cellgenic to Host Soft Opening of Advanced Cell Therapy Manufacturing Lab in Cancun
VANCOUVER, BC / ACCESS Newswire / August 25, 2025 / Rio Grande Resources Ltd. (CSE:RGR)(OTCQB:RGRLF)
DENVER, CO / ACCESS Newswire / August 25, 2025 / SOBR Safe, Inc. (Nasdaq:SOBR) (“SOBRsafe”
Management consulting firm announces new AI-Infused Business Model that delivers engagements at least 30% better,
Vickie Lasher’s, Mortgage Solutions Analyzes Potential Fed Rate Cuts and Their Impact on Homebuyers, Refinancing,
Wyckomar Inc., a global water treatment manufacturer and subsidiary of Energy Resource Abundance, Inc. (OTC:ERAO),
VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / August 25, 2025 / Alset AI Ventures Inc.
Pairing sustainable materials with “physical-to-digital” authentication to validate recycled-content claim and EPR compliance. NEW YORK,
Deal delivered at target 4-6× EBITDA range; strengthens platform with premium brands in high-growth construction
Marks a key milestone following the company’s public listing and continued growth as a U.S.-listed
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
BEVERLY HILLS, FL / ACCESS Newswire / August 25, 2025 / Green Rain Energy Holdings
FREMONT, CA / ACCESS Newswire / August 25, 2025 / Aehr Test Systems (NASDAQ:AEHR), a
VANCOUVER, BC / ACCESS Newswire / August 25, 2025 / Irving Resources Inc. (CSE:IRV)(OTCQX:IRVRF) (“Irving”
HONG KONG, HK / ACCESS Newswire / August 25, 2025 / Metafyed, a RWA marketplace
CEO Dan O’Toole wants to pay and get paid in Bitcoin INDIANAPOLIS, INDIANA / ACCESS
ARIS MINING TO BECOME A 19.9% SHAREHOLDER IN MCFARLANE LAKE PURSUANT TO THE US$22 MILLION
Breakthrough Therapy designation complements Rusfertide’s Orphan Drug and Fast Track designations, which together confer multiple